Truist Securities Maintains Hold on Medtronic, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Truist Securities has maintained a Hold rating on Medtronic and raised its price target from $85 to $90.
August 23, 2024 | 3:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Hold rating on Medtronic and increased the price target from $85 to $90, indicating a positive outlook.
The increase in the price target from $85 to $90 by Truist Securities suggests a positive outlook for Medtronic, which could lead to a short-term increase in stock price. However, the Hold rating indicates a neutral stance on immediate buying or selling.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100